Cervical Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019

Cervical Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019



Summary

GlobalData's Medical Devices sector report, “Cervical Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019 provides an overview of Cervical Cancer Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cervical Cancer Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Cervical Cancer Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cervical Cancer Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cervical Cancer Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


  • Introduction
    • Cervical Cancer Diagnostic Tests Overview
  • Products under Development
    • Cervical Cancer Diagnostic Tests - Pipeline Products by Stage of Development
      • Table Figure 1: Cervical Cancer Diagnostic Tests - Pipeline Products by Stage of Development
      • Table Cervical Cancer Diagnostic Tests - Pipeline Products by Stage of Development
    • Cervical Cancer Diagnostic Tests - Pipeline Products by Territory
      • Table Figure 2: Cervical Cancer Diagnostic Tests - Pipeline Products by Territory
      • Table Cervical Cancer Diagnostic Tests - Pipeline Products by Territory
    • Cervical Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
      • Table Figure 3: Cervical Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
      • Table Cervical Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
    • Cervical Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
      • Table Figure 4: Cervical Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
      • Table Cervical Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
    • Cervical Cancer Diagnostic Tests - Ongoing Clinical Trials
      • Table Figure 5:Cervical Cancer Diagnostic Tests - Ongoing Clinical Trials
      • Table Cervical Cancer Diagnostic Tests - Ongoing Clinical Trials
  • Cervical Cancer Diagnostic Tests - Pipeline Products under Development by Companies
    • Cervical Cancer Diagnostic Tests Companies - Pipeline Products by Stage of Development
      • Table Cervical Cancer Diagnostic Tests Companies - Pipeline Products by Stage of Development
    • Cervical Cancer Diagnostic Tests – Companies Pipeline Products by Stage of Development
      • Table Cervical Cancer Diagnostic Tests – Companies Pipeline Products by Stage of Development
  • Cervical Cancer Diagnostic Tests Companies and Product Overview
    • Alere Inc Company Overview
      • Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table NMP179 Test - Product Status
        • Table NMP179 Test - Product Description
    • Augusta University Company Overview
      • Augusta University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Augusta University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Folate Receptor Biomarker Test - Cervical Cancer Diagnostic Tests - Product Status
        • Table Folate Receptor Biomarker Test - Cervical Cancer Diagnostic Tests - Product Description
    • Becton Dickinson and Co Company Overview
      • Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview
        • Table Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview
        • Table BD SurePath Plus Molecular Pap Test System - Product Status
        • Table BD SurePath Plus Molecular Pap Test System - Product Description
        • Table Biomarker Test - Cervical Cancer Diagnostic Tests - Product Status
        • Table Biomarker Test - Cervical Cancer Diagnostic Tests - Product Description
        • Table Becton Dickinson and Co - Ongoing Clinical Trials Overview
        • Table BD SurePath Plus Molecular Pap Test System - Validation of High Resolution Microendoscope in the Screening of Cervical Cancer Precursor Lesions in Brazil: UH3 - Brazil
    • Bio Techne Corp Company Overview
      • Bio Techne Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bio Techne Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table RNAscope HPV Assay - Cervical Cancer Diagnostic Tests - Product Status
        • Table RNAscope HPV Assay - Cervical Cancer Diagnostic Tests - Product Description
    • BioAffinity Technologies, Inc. Company Overview
      • BioAffinity Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table BioAffinity Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table CyPath Diagnostic Assay - Cervical Cancer Diagnostic Tests - Product Status
        • Table CyPath Diagnostic Assay - Cervical Cancer Diagnostic Tests - Product Description
    • BioMark Diagnostics Inc Company Overview
      • BioMark Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table BioMark Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Metabolomics-based Diagnostic Assay - Cervical Cancer Diagnostic Tests - Product Status
        • Table Metabolomics-based Diagnostic Assay - Cervical Cancer Diagnostic Tests - Product Description
    • BioMark Technologies Inc Company Overview
      • BioMark Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table BioMark Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biomarker Assay - Cervical Cancer Diagnostic Tests - Product Status
        • Table Biomarker Assay - Cervical Cancer Diagnostic Tests - Product Description
    • Cepheid Company Overview
      • Cepheid Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cepheid Pipeline Products & Ongoing Clinical Trials Overview
        • Table Xpert Molecular PAP Assay - Product Status
        • Table Xpert Molecular PAP Assay - Product Description
    • China Sky One Medical Inc Company Overview
      • China Sky One Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table China Sky One Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Kit - Carcinoma Cervix - Product Status
        • Table Diagnostic Kit - Carcinoma Cervix - Product Description
    • Cytosystems Ltd Company Overview
      • Cytosystems Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cytosystems Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Laboratory-Based Diagnostic Test - Cervical Cancer Diagnostic Tests - Product Status
        • Table Laboratory-Based Diagnostic Test - Cervical Cancer Diagnostic Tests - Product Description
    • Enzo Biochem Inc Company Overview
      • Enzo Biochem Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Enzo Biochem Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table p16 Biomarker - Cervical Cancer Diagnostic Tests - Product Status
        • Table p16 Biomarker - Cervical Cancer Diagnostic Tests - Product Description
    • Exact Sciences Corp Company Overview
      • Exact Sciences Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Exact Sciences Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Liquid Biopsy Test - Cervical Cancer Diagnostic Tests - Product Status
        • Table Liquid Biopsy Test - Cervical Cancer Diagnostic Tests - Product Description
    • GenomicTree Inc Company Overview
      • GenomicTree Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table GenomicTree Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table EarlyTect Cervical Cancer Diagnostic Tests - Product Status
        • Table EarlyTect Cervical Cancer Diagnostic Tests - Product Description
        • Table Screening Test - Cervical Cancer Diagnostic Tests - Product Status
        • Table Screening Test - Cervical Cancer Diagnostic Tests - Product Description
    • GRANT Life Sciences, Inc. Company Overview
      • GRANT Life Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table GRANT Life Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Serum-Based Test - Cervical Cancer Diagnostic Tests - Product Status
        • Table Serum-Based Test - Cervical Cancer Diagnostic Tests - Product Description
    • HLL Lifecare Ltd Company Overview
      • HLL Lifecare Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table HLL Lifecare Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic ELISA - Cervical Cancer Diagnostic Tests - Product Status
        • Table Diagnostic ELISA - Cervical Cancer Diagnostic Tests - Product Description
    • Louisville Bioscience, Inc. Company Overview
      • Louisville Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Louisville Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cervical Cancer Remission pT Test - Product Status
        • Table Cervical Cancer Remission pT Test - Product Description
    • MDNA Life Sciences Inc Company Overview
      • MDNA Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table MDNA Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cervical Mitomic Test - Product Status
        • Table Cervical Mitomic Test - Product Description
    • MDxHealth SA Company Overview
      • MDxHealth SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table MDxHealth SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table ClinicalMDx - Cervical Cancer Diagnostic Tests - Product Status
        • Table ClinicalMDx - Cervical Cancer Diagnostic Tests - Product Description
    • Milagen Inc Company Overview
      • Milagen Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Milagen Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Immunoassay - Cervical Cancer Diagnostic Tests - Product Status
        • Table Immunoassay - Cervical Cancer Diagnostic Tests - Product Description
    • Olympia Diagnostics Inc Company Overview
      • Olympia Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Olympia Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Test - Cervical Cancer Diagnostic Tests - Product Status
        • Table Diagnostic Test - Cervical Cancer Diagnostic Tests - Product Description
        • Table Prognostic Test - Cervical Cancer Diagnostic Tests - Product Status
        • Table Prognostic Test - Cervical Cancer Diagnostic Tests - Product Description
    • Oncgnostics GmbH Company Overview
      • Oncgnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Oncgnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table GynTect - Product Status
        • Table GynTect - Product Description
    • ONCOVEDA Cancer Research Center Company Overview
      • ONCOVEDA Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview
        • Table ONCOVEDA Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview
        • Table HPV Companion Diagnostic Test - Cervical Cancer Diagnostic Tests - Product Status
        • Table HPV Companion Diagnostic Test - Cervical Cancer Diagnostic Tests - Product Description
    • Precision Biologics Inc Company Overview
      • Precision Biologics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Precision Biologics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Assay - Cervical Cancer Diagnostic Tests - Product Status
        • Table Diagnostic Assay - Cervical Cancer Diagnostic Tests - Product Description
    • US Biomarkers Inc Company Overview
      • US Biomarkers Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table US Biomarkers Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Blood-Based Biomarker - Cervical Cancer Diagnostic Tests - Product Status
        • Table Blood-Based Biomarker - Cervical Cancer Diagnostic Tests - Product Description
    • XEPTAGEN SpA Company Overview
      • XEPTAGEN SpA Pipeline Products & Ongoing Clinical Trials Overview
        • Table XEPTAGEN SpA Pipeline Products & Ongoing Clinical Trials Overview
        • Table SCCA - IgM Kit - Cervical Cancer Diagnostic Tests - Product Status
        • Table SCCA - IgM Kit - Cervical Cancer Diagnostic Tests - Product Description
  • Cervical Cancer Diagnostic Tests - Recent Developments
    • Nov 05, 2019: BD announces results for 2019 fourth fiscal quarter and full year; provides fiscal 2020 guidance
    • Oct 30, 2019: Genomic Vision: Financial information for the third quarter of 2019
    • Oct 23, 2019: AdvaMed Statement on BD Sterilization Plant in Georgia
    • Oct 22, 2019: Quest Diagnostics reports third quarter 2019 financial results
    • Oct 03, 2019: Genomic Vision and PolyAn sign an agreement for the production and supply of Coverslips
    • Sep 26, 2019: BD announces leadership succession plan
    • Sep 24, 2019: Genomic Vision: First-half 2019 results
    • Sep 10, 2019: Quest Diagnostics names Manuel O. Méndez as new commercial leader
    • Aug 29, 2019: MDxHealth reports half year 2019 financial results and strategic update
    • Aug 26, 2019: New technique isolates placental cells for non-invasive genetic testing
    • Aug 20, 2019: Cancer Genetics reports second quarter 2019 financial results and provides strategic business update
    • Aug 06, 2019: BD announces results for 2019 third fiscal quarter; reaffirms fiscal 2019 guidance
    • Jul 26, 2019: Genomic Vision: Financial information for the first half of 2019
    • Jul 25, 2019: BD Statement on Georgia facilities
    • Jul 23, 2019: Quest Diagnostics reports second quarter 2019 financial results
    • Jul 23, 2019: Microfluidic array catches, holds single cervical cells for faster screening
    • Jul 18, 2019: Quest Diagnostics welcomes new members to the Global Diagnostics Network (GDN)
    • Jun 17, 2019: BD announces new leadership for BD Biosciences
    • Jun 03, 2019: Quest Diagnostics Statement on the AMCA Data Security Incident
    • May 20, 2019: Cancer Genetics reports first quarter 2019 financial results and provides strategic business update
    • May 14, 2019: American Medical Collection Agency announces privacy and security statement
    • May 09, 2019: BD announces results for 2019 second fiscal quarter; updates fiscal 2019 guidance
    • May 02, 2019: Genomic Vision: Financial information for the first quarter of 2019
    • Apr 29, 2019: Urine test could prevent cervical cancer
    • Apr 24, 2019: MDxHealth provides Q1 2019 business update
    • Apr 24, 2019: U of T Researchers receive 1.5 million to improve cancer screening among Indigenous People
    • Apr 23, 2019: Quest Diagnostics reports first quarter 2019 financial results
    • Apr 18, 2019: Peter Mac board announces new chief executive
    • Apr 16, 2019: Cancer Genetics reports fourth quarter and full year 2018 financial results and provides strategic business updates
    • Apr 04, 2019: Screening also prevents rare types of cervical cancer
    • Mar 29, 2019: Administration Strips Planned Parenthood FY2019 Title X Funding in Obvious Move to Push Planned Parenthood Patients Out of Program
    • Mar 27, 2019: ONO announces a strategic drug discovery alliance agreement with Cancer Research UK and LifeArc for cancer immunotherapy
    • Mar 06, 2019: Genomic Vision: 2018 annual results
    • Feb 28, 2019: MDxHealth reports financial year 2018 results and provides outlook for 2019
    • Feb 20, 2019: Early detection test GynTect now available on Roche Diagnostics' QPCR system
    • Feb 19, 2019: MDxHealth names Michael K. McGarrity as CEO
    • Feb 19, 2019: Quest Diagnostics elects Denise Morrison to board of directors
    • Feb 18, 2019: Genomica and HuaSin advancing fight against cervical cancer in China
    • Feb 14, 2019: Quest Diagnostics reports fourth quarter and full year 2018 financial results; provides guidance for full year 2019
    • Feb 13, 2019: Prevent Cancer Foundation awards $400,000 in global community grants
    • Feb 06, 2019: Genomic Vision: Financial information for the fourth quarter of 2018
    • Feb 05, 2019: BD announces results for 2019 first fiscal quarter; reaffirms fiscal 2019 guidance
    • Jan 24, 2019: Preventing cervical cancer: how a screening switch and HPV vaccination should cut cancer rates
    • Jan 17, 2019: BD announces preliminary results for 2019 first fiscal quarter; reaffirms fiscal 2019 guidance
    • Jan 17, 2019: Using Artificial Intelligence to detect Cervical Cancer
    • Jan 14, 2019: MDxHealth provides business update
    • Jan 11, 2019: Genomic Vision announces the convening of an extraordinary shareholders' meeting on February 15, 2019, and provides an update on its financial situation
    • Jan 10, 2019: AI approach outperformed human experts in identifying cervical precancer
    • Jan 09, 2019: Cancer Genetics strengthens management team with appointment of William Finger as Executive Vice President, precision medicine and pharma services
    • Dec 18, 2018: Catalyst Health Network and UnitedHealthcare's accountable care organization relationship fostering quality care at lower cost
    • Dec 14, 2018: New cervical cancer test has 100 per cent detection rate
    • Dec 06, 2018: Genisphere names Brian P. McVeigh as Board Director
    • Nov 28, 2018: Quest Diagnostics to Build Flagship Laboratory at Visionary Campus in Clifton, New Jersey to Empower Better Health for Patients in Seven States
    • Nov 28, 2018: Quest Diagnostics to discuss strategic growth drivers and financial outlook at 2018 Investor Day
    • Nov 23, 2018: GV and Phyteneo agree to sell HPV Integration Test in Czech Republic
    • Nov 19, 2018: Cancer Genetics announces third quarter 2018 financial results
    • Nov 15, 2018: Cancer screening to be overhauled as part of NHS long term plan to improve care and save lives
    • Nov 14, 2018: Cancer Genetics appoints Glenn Miles as Chief Financial Officer
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook